Aleksandr Stiblo attended VIII Life Sciences Invest. Partnering Russia forum

Last week Aleksandr Stiblo, GCT Deputy Director Business Development, participated at the VIII International forum “Life Sciences Invest. Partnering Russia” in St. Petersburg, Russia.

It is a great opportunity to enhance the business contacts of companies and investors within life sciences industry in Russia.  The Forum aims at supporting current federal initiatives to develop the pharmaceutical market as one of the key areas that provide a comfortable life and stability, creating the basis for a dynamic economic growth of the country.

Thanks to its biggest population in Europe and high qualification of investigators, Russia has a great potential for clinical trials. FDA and EMEA inspections confirm the high quality of clinical data. The government continues to reduce administrative barriers and simplify registration procedures in the Russian Federation.

GCT has 17 years of experience on the clinical trials market in Russia in different phases and indications. To discuss potential project, please write to bd@gctrials.com.

 

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2019 Global Clinical Trials, LLC

All rights reserved.